Skip to content
knowrare
HealthSignal
Your condition community

Living with 2q23.1 microdeletion syndrome

A rare chromosome condition that can bring seizures, learning and speech delays, sleep trouble, and behavior concerns.

Understanding 2q23.1 microdeletion syndrome

2q23.1 microdeletion syndrome is a rare chromosome condition caused by losing a small piece of DNA on chromosome 2.

Symptoms may include seizures, moderate to severe learning problems, speech delays, behavior problems, trouble sleeping, and delayed milestones. Children may also have low muscle tone (hypotonia), slow weight gain, and be shorter than family members. Most cases are de novo, meaning the deletion was not passed down from a parent. Genetic testing confirms the diagnosis. GARD lists onset as the newborn and infant period.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Delayed speech and language
  • Low muscle tone (hypotonia)
  • Severe intellectual disability
  • Sleep disturbance
  • Small head size (microcephaly)
  • Hyperactivity

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include brain and nervous system specialists, genetic specialists and seizure and epilepsy specialists.

  3. Ask which tests can help

    Your care team will decide which exams and tests can confirm the diagnosis.

  4. Connect with expert centers

    Epilepsy Foundation may keep lists of experts for this condition.

Care & treatment

Care team
Brain and nervous system specialists (neurologists); Genetic specialists (geneticists); Seizure and epilepsy specialists (epileptologist)
Expert care
Expert lists: Epilepsy Foundation
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Simons Searchlight and other patient organizations
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
What can help my child with sleep problems?
Should my child see a neurologist about seizures?
Does genetic testing show whether this was new in my child?

Quick facts

Symptoms usually startNewborn and as an Infant

GARD says changes in genes (also called variants) cause this condition. It is caused by the loss of a small piece of DNA in one copy of chromosome 2, and most cases are not passed down from a parent.

GeneticNeurological

Also known as: del(2)(q23.1); monosomy 2q23.1; pseudo-angelman syndrome

Patient organizations

Source: NIH GARD · 2q23.1 microdeletion syndromeGARD ID 10998 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with 2q23.1 microdeletion syndrome.

Explore the 2q23.1 microdeletion syndrome blog

Explore research for 2q23.1 microdeletion syndrome

Explore actively recruiting 2q23.1 microdeletion syndrome studies with HealthSpark.

HealthSpark

Find actively recruiting studies for 2q23.1 microdeletion syndrome with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting 2q23.1 microdeletion syndrome studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for 2q23.1 microdeletion syndrome

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor 2q23.1 microdeletion syndrome

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your 2q23.1 microdeletion syndrome experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.